An SLE patient with persistent elevated conjugated bilirubin as
the initial symptom: a case report
Jun Liu1, Ying Huang1, Tingting
Shen1, Xingyi Li2, Fang
Zhao3, Xiaoxia Liu4, Shan
Zhang4 ,Pengjia Wu4, Na
Li4, Long Li4*, and Jiashun
Zeng4
1Department of Rheumatology and Immunology, The
Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou,
China;ljsy013186vip.@qq.com.
1Department of Rheumatology and Immunology, The 2nd
Hospital Affiliated to Guizhou University of Chinese Traditional
Medicine, Guiyang, Guizhou Province, China;40741698@qq.com.
1Guizhou Provincial People’s Hospital, Guiyang,
Guizhou Province, China;286165007@qq.com.
2Guizhou Medical University, Guizhou Province,
China.3045629556@qq.com.
3Guizhou Medical University, Guizhou Province, China.
;626791899@qq.com.
4Department of Rheumatology and Immunology, The
Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou,
China; liuxiaoxiarain@163.com.
4Department of Rheumatology and Immunology, The
Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou,
China; shanzhang_ncu@qq.com.
4Department of Rheumatology and Immunology, The
Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou,
China; 1015066791@qq.com.
4Department of Rheumatology and Immunology, The
Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou,
China; 793875371@qq.com.
4*Department of Rheumatology and Immunology, The
Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou,
China; gzyxyll@medmail.com.cn.
4Department of Rheumatology and Immunology, The
Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou,
China; zengjiashun@sina.com.
Written informed consent was obtained from the patient to publish this
report in accordance with the journal’s patient consent policy
1.Data availability statement: All relevant data are within the paper.
2.funding statement: This research did not receive any specific grant
from funding agencies in the public, commercial, or not-for-profit
sectors.
3.conflict of interest disclosure: All authors have no conflicts of
interest. On behalf of all authors, the corresponding author states that
there is no conflict of interest.
4.ethics approval statement: The ethics committee approval from the
authors’ institution have been obtained for this study.
5.patient consent statement: Patients’ informed consent have been
obtained for this study.
6.permission to reproduce material from other sources: The study allows
reproduction of the material from other sources.
7.clinical trial registration:The study was retrospective and therefore
not registered in clinical trials.